Biomarker Qualification at the European Medicines Agency : A Look Under the Hood
| Errataetall: |
CommentOn: Clin Pharmacol Ther. 2022 Jul;112(1):69-80. - PMID 35137949 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:112 |
|---|---|
| Enthalten in: |
Clinical pharmacology and therapeutics - 112(2022), 1 vom: 01. Juli, Seite 28-30 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Berman, Steven [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.06.2022 Date Revised 12.09.2022 published: Print-Electronic CommentOn: Clin Pharmacol Ther. 2022 Jul;112(1):69-80. - PMID 35137949 Citation Status MEDLINE |
|---|
| doi: |
10.1002/cpt.2609 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340292997 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340292997 | ||
| 003 | DE-627 | ||
| 005 | 20231226004820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cpt.2609 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1134.xml |
| 035 | |a (DE-627)NLM340292997 | ||
| 035 | |a (NLM)35500535 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Berman, Steven |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomarker Qualification at the European Medicines Agency |b A Look Under the Hood |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.06.2022 | ||
| 500 | |a Date Revised 12.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Clin Pharmacol Ther. 2022 Jul;112(1):69-80. - PMID 35137949 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Siegel, Jeffrey |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pharmacology and therapeutics |d 1960 |g 112(2022), 1 vom: 01. Juli, Seite 28-30 |w (DE-627)NLM000015318 |x 1532-6535 |7 nnns |
| 773 | 1 | 8 | |g volume:112 |g year:2022 |g number:1 |g day:01 |g month:07 |g pages:28-30 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cpt.2609 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 112 |j 2022 |e 1 |b 01 |c 07 |h 28-30 | ||